CK Life Sciences Int'l., (Holdings) Inc. (00775) reported that its authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD 0.1, totaling HKD 1,500,000,000 at the end of January 2026. The number of issued shares stood at 9,611,072,400 with no treasury shares, reflecting no changes from the previous month.

The company confirmed that it satisfied the applicable public float requirement of 25% of its total issued shares as of January 31, 2026, and no movements were recorded for share options, warrants, or any other convertible instruments during the period under review.